Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We want to study the effect of the combination of metoprolol (a beta-blocker) with formoterol
(a beta-agonist) on long function in patients with Chronic Obstructive Pulmonary Disease
(COPD). There are more and more clues that a beta-blocker, when well chosen and in the right
dosage, won't harm the long function in patients with COPD. Since a beta-blocker can be a
valuable addition to treating patients with heart problems we would like to see if this
category of medication can be available for COPD patients in the future.